Medindia LOGIN REGISTER
Medindia
Advertisement

Imaging Diagnostic Systems Sells Its CT Laser Mammography System to Budapest, Hungary

Wednesday, October 15, 2008 General News
Advertisement
FORT LAUDERDALE, Fla., Oct. 14 ImagingDiagnostic Systems, Inc., (OTC Bulletin Board: IMDS) a pioneer in laseroptical breast cancer imaging systems, announced today that its distributor,Laszlo Meszaros of Kardia Hungary Kft., has purchased the first CT LaserMammography (CTLM(R)) system for Budapest, Hungary.
Advertisement

(Logo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO )

The CTLM system will be installed at the new MeDoc HealthCare Center(MDHC) located in Budapest, in collaboration with Dr. Maria Gergely/ChiefRadiologist of Uzsoki Hospital. "I am very excited to have this opportunityto provide my patients with more comprehensive imaging and I hope to find morecancers in the dense breast patients where it is most difficult to image withtoday's current technologies," commented Dr. Gergely.
Advertisement

MDHC is a new privately operated medical center that focuses on the latestdetection for cancer by offering its patients the most current and cuttingedge imaging equipment.

Dr. Andras Vertes, CEO/MDHC commented, "I am looking forward to workingwith the CTLM system and believe it will fit in very well with our othermodalities."

"We will continue to focus on obtaining recognition for the CTLM system inthe International markets through our distribution network, reference sites,Imaging Conferences and Symposiums in hopes to generate additional sales,"quoted Linda B Grable/CEO of Imaging Diagnostic Systems.

About Imaging Diagnostic Systems, Inc.

Imaging Diagnostic Systems, Inc. has developed a revolutionary breastimaging device to aid in the detection and management of breast cancer. TheCTLM system is a breast imaging system that utilizes patented continuous wavelaser technology and computer algorithms to create 3-D images of the breast.The procedure is non-invasive, painless, and does not expose the patient toionizing radiation or painful breast compression. CTLM is designed to be usedin conjunction with mammography. It reveals information about blooddistribution in the breast and may visualize the process of angiogenesis,which usually accompanies tumor growth.

Imaging Diagnostic Systems is currently collecting data from clinicalsites for the future filing of an FDA Premarket Approval (PMA) for theComputed Tomography Laser Mammography system to be used as an adjunct tomammography. The FDA has determined that the Company's clinical study is anon-significant risk (NSR) investigational device study under 812.3(m) of theinvestigational device exemptions (IDE) regulation (21 CFR 812). The CTLMsystem is limited by United States Federal Law to investigational use only inthe United States. The CTLM system has received other registrations includingCE, CMDCAS Canadian License, China SFDA, UL, ISO 9001:2000, ISO 13485:2003 andFDA export certification.

For more information, visit our website: http://www.imds.com .

As contemplated by the provisions of the Safe Harbor section of thePrivate Securities Litigation Reform Act of 1995, this news release maycontain forward-looking statements pertaining to future, anticipated, orprojected plans, performances and developments, as well as other statementsrelating to future operations. All such forward-looking statements arenecessarily only estimates or predictions of future results or events andthere can be no assurance that actual results or events will not materiallydiffer from expectations. Further information on potential factors that couldaffect Imaging Diagnostic Systems, Inc., is included in the Company's filingswith the Securities and Exchange Commission. We expressly disclaim any intentor obligation to update any forward-looking statements.

SOURCE Imaging Diagnostic Systems, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close